Risk of kidney cancer and chronic kidney disease in relation to hepatitis C virus infection: A nationwide register-based cohort study in Sweden

European Journal of Cancer Prevention

Volumn 20, Issue 4, 2011, Pages 326-330

  Hofmann, Jonathan N ^a   Törner, Anna ^b   Chow, Wong Ho ^a   Ye, Weimin ^c   Purdue, Mark P ^a   Duberg, Ann Sofi ^d  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

Author keywords

cancer registry; chronic hepatitis C virus infection; chronic kidney disease; kidney cancer; renal cell carcinoma

Indexed keywords

ADULT; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; FEMALE; FOLLOW UP; HEPATITIS C; HOSPITALIZATION; HUMAN; KIDNEY CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REGISTER; SWEDEN;

ADULT; CARCINOMA, RENAL CELL; COHORT STUDIES; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; KIDNEY NEOPLASMS; MALE; PROGNOSIS; REGISTRIES; RISK FACTORS; SURVIVAL RATE; SWEDEN;

EID: 79958782231     PISSN: 09598278     EISSN: 14735709     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e32834572fa     Document Type: Article

References (21)

1. Amin J, Dore GJ, O'Connell DL, Bartlett M, Tracey E, Kaldor JM, Law MG (2006). Cancer incidence in people with hepatitis B or C infection: a large community-based linkage study. J Hepatol 45:197-203.
2. Cao Y, Zhang Y, Wang S, Zou W (2009). Detection of the hepatitis C virus antigen in kidney tissue from infected patients with various glomerulonephritis. Nephrol Dial Transplant 24:2745-2751.
3. Carrero JJ (2010). Gender differences in chronic kidney disease: underpinnings and therapeutic implications. Kidney Blood Press Res 33:383-392.
4. Chow WH, Dong LM, Devesa SS (2010). Epidemiology and risk factors for kidney cancer. Nat Rev Urol 7:245-257.
5. Dal Maso L, Franceschi S (2006). Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms: a meta-analysis of epidemiologic studies. Cancer Epidemiol Biomarkers Prev 15:2078-2085. (Pubitemid 44877029)
6. Duberg AS, Nordstrom M, Torner A, Reichard O, Strauss R, Janzon R, et al. (2005). Non-Hodgkin's lymphoma and other nonhepatic malignancies in Swedish patients with hepatitis C virus infection. Hepatology 41:652-659. (Pubitemid 40289514)
7. Duberg AS, Torner A, Davidsdottir L, Aleman S, Blaxhult A, Svensson A, et al. (2008). Cause of death in individuals with chronic HBV and/or HCV infection, a nationwide community-based register study. J Viral Hepat 15:538-550. (Pubitemid 351798992)
8. Duberg AS, Pettersson H, Aleman S, Blaxhult A, Daviethsdottir L, Hultcrantz R, et al. (2010). The burden of hepatitis C in Sweden: a national study of inpatient care. J Viral Hepat 18:106-118. [Epub ahead of print].
9. Gordon SC, Moonka D, Brown KA, Rogers C, Huang MA, Bhatt N, Lamerato L (2010). Risk for renal cell carcinoma in chronic hepatitis C infection. Cancer Epidemiol Biomarkers Prev 19:1066-1073.
10. Iseki K (2008). Gender differences in chronic kidney disease. Kidney Int 74: 415-417.
11. Jansson A, Arneborn M, Ekdahl K (2005). Sensitivity of the Swedish statutory surveillance system for communicable diseases 1998-2002, assessed by the capture-recapture method. Epidemiol Infect 133:401-407. (Pubitemid 40867676)
12. Lavanchy D (2009). The global burden of hepatitis C. Liver Int 29:74-81.
13. London WT, McGlynn KA (2006). Liver Cancer. In: Schottenfeld D, Fraumeni JF Jr, editors. Cancer epidemiology and prevention. 3rd ed. New York: Oxford University Press. pp. 763-786.
14. Mattson B (1984). Cancer registration in Sweden: studies on completeness and validity of incidence and mortality registers [dissertation]. Stockholm, Sweden: Karolinska Institutet.
15. Meyers CM, Seeff LB, Stehman-Breen CO, Hoofnagle JH (2003). Hepatitis C and renal disease: an update. Am J Kidney Dis 42:631-657. (Pubitemid 37187365)
16. Perico N, Cattaneo D, Bikbov B, Remuzzi G (2009). Hepatitis C infection and chronic renal diseases. Clin J Am Soc Nephrol 4:207-220.
17. Poynard T, Yuen MF, Ratziu V, Lai CL (2003). Viral hepatitis C. Lancet 362: 2095-2100. (Pubitemid 38035201)
18. Sansonno D, Lauletta G, Montrone M, Grandaliano G, Schena FP, Dammacco F (2005). Hepatitis C virus RNA and core protein in kidney glomerular and tubular structures isolated with laser capture microdissection. Clin Exp Immunol 140:498-506. (Pubitemid 40813960)
19. Strauss R, Torner A, Duberg AS, Hultcrantz R, Ekdahl K (2008). Hepatocellular carcinoma and other primary liver cancers in hepatitis C patients in Sweden-a low endemic country. J Viral Hepat 15:531-537. (Pubitemid 351798991)
20. Torner A, Duberg AS, Dickman P, Svensson A (2010). A proposed method to adjust for selection bias in cohort studies. Am J Epidemiol 171:602-608.
21. Tsui JI, Vittinghoff E, Shlipak MG, Bertenthal D, Inadomi J, Rodriguez RA, O'Hare AM (2007). Association of hepatitis C seropositivity with increased risk for developing end-stage renal disease. Arch Intern Med 167:1271-1276. (Pubitemid 46998498)